ACLS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ACLS is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has strong short-term technical momentum and a favorable option sentiment reading, but the latest quarter shows deteriorating profitability and the most recent analyst/insider trends are mixed to negative. Because the user wants a direct answer and is not waiting for an ideal entry, my view is to hold off on buying now and wait for clearer fundamental improvement and a more attractive entry.
Technically, ACLS is still in an uptrend on the chart: SMA_5 is above SMA_20 and SMA_200, and the MACD histogram is positive and expanding, which confirms bullish momentum. RSI_6 at 67.27 is near overbought but not extreme, so the stock still has room to move, though near-term upside may be limited after the sharp drop from 171 to 146.62. The pivot level is 148.50, and the stock closed slightly below it, which suggests the recent move has weakened. Overall, the trend is bullish over the medium term, but the current price action looks unstable and not ideal for a long-term beginner entry.
["B. Riley upgraded ACLS to Buy and raised the price target to $150 from $91.", "Analyst commentary points to better Q1 results versus consensus and improving Q2 visibility.", "The pending all-stock Veeco merger is a strategic catalyst.", "Revenue in the latest quarter grew 3.32% year over year.", "Technical trend remains bullish with SMA_5 > SMA_20 > SMA_200 and a positive MACD."]
["The stock dropped sharply in the latest session, closing at 146.62 from 171, showing heavy recent weakness.", "Insiders are selling, and selling activity increased 1048.06% over the last month.", "BofA remains Underperform with a $90 target, reflecting skepticism.", "Net income fell 67.76% YoY and EPS fell 65.91% YoY in Q1 2026.", "Gross margin declined to 40.5%, down 12.15% YoY.", "No recent news catalyst in the past week.", "No recent congress trading data or influential figure buying support was reported."]
In Q1 2026, Axcelis posted revenue of $198.956M, up 3.32% year over year, which shows modest top-line growth. However, profitability weakened significantly: net income fell to $9.214M, down 67.76% YoY, EPS dropped to $0.30 from the prior year, down 65.91%, and gross margin slipped to 40.5% from a much stronger year-ago level. This is a growth-in-revenue but deterioration-in-profitability quarter, which is not ideal for a long-term beginner investment.
Recent analyst action is mixed but leaning positive on balance. B. Riley upgraded ACLS to Buy with a $150 target, citing stronger near-term results, improving memory demand, stabilizing China, and the Veeco merger catalyst. But just months earlier, B. Riley had been Neutral with a $91 target, and BofA still rates the stock Underperform with a $90 target. Wall Street pros seem divided: bulls like the strategic catalysts and rebound potential, while bears focus on weak profitability, China exposure, and softer forward fundamentals.
